8DZ Stock Overview
Engages in the development and sale of cannabis products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nevis Brands Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.044 |
| 52 Week High | US$0.099 |
| 52 Week Low | US$0.014 |
| Beta | 0.20 |
| 11 Month Change | 9.88% |
| 3 Month Change | -20.54% |
| 1 Year Change | 11.25% |
| 33 Year Change | 0% |
| 5 Year Change | n/a |
| Change since IPO | -68.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8DZ | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 18.7% | -0.6% | -0.2% |
| 1Y | 11.3% | -7.2% | 7.8% |
Return vs Industry: 8DZ exceeded the German Personal Products industry which returned -6% over the past year.
Return vs Market: 8DZ exceeded the German Market which returned 7.9% over the past year.
Price Volatility
| 8DZ volatility | |
|---|---|
| 8DZ Average Weekly Movement | 29.2% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8DZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8DZ's weekly volatility (29%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 2 | John Kueber | www.nevisbrands.com |
Nevis Brands Inc. engages in the development and sale of cannabis products in the United States. It offers cannabis infused beverage under the Major brand name. The company was formerly known as Pascal Biosciences Inc. and changed its name to Nevis Brands Inc. in June 2023.
Nevis Brands Inc. Fundamentals Summary
| 8DZ fundamental statistics | |
|---|---|
| Market cap | €2.50m |
| Earnings (TTM) | -€220.83k |
| Revenue (TTM) | €1.14m |
2.2x
P/S Ratio-11.3x
P/E RatioIs 8DZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8DZ income statement (TTM) | |
|---|---|
| Revenue | CA$1.69m |
| Cost of Revenue | CA$552.72k |
| Gross Profit | CA$1.14m |
| Other Expenses | CA$1.46m |
| Earnings | -CA$326.73k |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0085 |
| Gross Margin | 67.25% |
| Net Profit Margin | -19.36% |
| Debt/Equity Ratio | 43.6% |
How did 8DZ perform over the long term?
See historical performance and comparison